X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
everolimus (25) 25
drug-eluting stents (24) 24
sirolimus - analogs & derivatives (24) 24
male (23) 23
treatment outcome (23) 23
cardiac & cardiovascular systems (22) 22
female (22) 22
middle aged (22) 22
aged (20) 20
time factors (20) 20
sirolimus - administration & dosage (18) 18
coronary artery disease - therapy (16) 16
cardiovascular agents - administration & dosage (15) 15
absorbable implants (14) 14
angioplasty, balloon, coronary - instrumentation (14) 14
cardiovascular (13) 13
coronary angiography (13) 13
prosthesis design (13) 13
angioplasty, balloon, coronary - adverse effects (12) 12
coronary artery disease (11) 11
implantation (11) 11
stents (11) 11
europe (10) 10
kaplan-meier estimate (10) 10
prospective studies (10) 10
ultrasonography, interventional (10) 10
follow-up studies (9) 9
single-blind method (9) 9
coronary artery disease - diagnostic imaging (8) 8
intravascular ultrasound (8) 8
new zealand (8) 8
optical coherence tomography (8) 8
risk factors (8) 8
cardiology and cardiovascular medicine (7) 7
coronary restenosis - etiology (7) 7
coronary vessels - diagnostic imaging (7) 7
myocardial infarction - etiology (7) 7
abridged index medicus (6) 6
angioplasty (6) 6
angioplasty, balloon, coronary - mortality (6) 6
coronary artery disease - mortality (6) 6
paclitaxel - administration & dosage (6) 6
percutaneous coronary intervention (6) 6
predictive value of tests (6) 6
risk assessment (6) 6
thrombosis - etiology (6) 6
tissue scaffolds (6) 6
2nd-generation (5) 5
absorb (5) 5
absorb bioresorbable vascular scaffold (5) 5
bioresorbable scaffold (5) 5
cardiology (5) 5
coronary vessels (5) 5
restenosis (5) 5
trial (5) 5
angiography (4) 4
coronary artery disease - diagnosis (4) 4
coronary stenosis - therapy (4) 4
coronary vessels - pathology (4) 4
drug-eluting stents - adverse effects (4) 4
internal medicine (4) 4
medical imaging (4) 4
sirolimus (4) 4
thrombosis (4) 4
tomography, optical coherence (4) 4
1st human-experience (3) 3
coronary restenosis - prevention & control (3) 3
coronary stenosis - diagnostic imaging (3) 3
disease (3) 3
drug-eluting stent (3) 3
edge vascular response (3) 3
everolimus-eluting stent (3) 3
feasibility studies (3) 3
fibrosis (3) 3
follow-up (3) 3
future-i (3) 3
heart attacks (3) 3
incidence (3) 3
india (3) 3
ivus (3) 3
metals (3) 3
multicenter studies as topic (3) 3
myocardial ischemia - etiology (3) 3
outcomes (3) 3
paclitaxel-eluting stent (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
randomized clinical trial (3) 3
randomized controlled trials as topic (3) 3
retrospective studies (3) 3
severity of illness index (3) 3
stent system (3) 3
system (3) 3
usage (3) 3
acquisition (2) 2
adult (2) 2
analysis (2) 2
angioplasty, balloon, coronary (2) 2
atherosclerosis (2) 2
australia (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2010, Volume 122, Issue 22, pp. 2301 - 2312
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 12/2009, Volume 2, Issue 12, pp. 1190 - 1198
Journal Article
American Heart Journal, ISSN 0002-8703, 11/2012, Volume 164, Issue 5, pp. 654 - 663
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2015, Volume 8, Issue 8, pp. 1053 - 1063
Journal Article
Atherosclerosis, ISSN 0021-9150, 2011, Volume 221, Issue 1, pp. 106 - 112
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 164, Issue 5, pp. 654 - 663
Background Currently, no data are available on the direct comparison between the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) and... 
Cardiovascular | Clinical trials | Cardiovascular disease | Medical imaging | Stents | Coronary vessels
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 10/2012, Volume 5, Issue 5, pp. 620 - 632
BACKGROUND—Nonserial observations have shown this bioresorbable scaffold to have no signs of area reduction at 6 months and recovery of vasomotion at 1 year.... 
Coronary artery disease | Coronary intervention and bioresorbable scaffold | coronary artery disease | SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | RADIOFREQUENCY DATA-ANALYSIS | CLINICAL-TRIAL | OPTICAL COHERENCE TOMOGRAPHY | FOLLOW-UP | STENT IMPLANTATION | coronary intervention and bioresorbable scaffold | MEDIUM-TERM | CORONARY-ARTERY LESIONS | INTRAVASCULAR ULTRASOUND | OUTCOMES | Coronary Vessels - diagnostic imaging | Predictive Value of Tests | Coronary Thrombosis - diagnosis | Angioplasty, Balloon, Coronary - instrumentation | Coronary Vessels - physiopathology | Humans | Middle Aged | Ultrasonography, Interventional | Male | Prosthesis Design | Diagnostic Imaging - methods | Tissue Scaffolds | Angioplasty, Balloon, Coronary - adverse effects | Coronary Restenosis - diagnosis | Neointima | Coronary Artery Disease - physiopathology | Time Factors | Female | Everolimus | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Tomography, Optical Coherence | Europe | Risk Factors | Treatment Outcome | Coated Materials, Biocompatible | Absorbable Implants | New Zealand | Coronary Angiography | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Aged | Coronary Thrombosis - etiology | Australia
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 13, pp. E317 - E317
Results There was one periprocedural myocardial infarction and two proximal edge target lesion revascularizations, which resulted in 2-year major adverse... 
Cardiovascular | Internal Medicine | Drug therapy | Cardiology
Journal Article
Heart, ISSN 1355-6037, 01/2013, Volume 99, Issue 2, pp. 98 - 105
Journal Article
EuroIntervention, ISSN 1774-024X, 01/2012, Volume 7, Issue 9, pp. 1060 - 1061
Aims: The first-in-man ABSORB Cohort A trial demonstrated the bioresorption of the ABSORB BVS (Abbott Vascular, Santa Clara, CA, USA) at two years. This report... 
Long-term outcome | Bioresorbable scaffold | Coronary artery disease | coronary artery disease | long-term outcome | CARDIAC & CARDIOVASCULAR SYSTEMS | bioresorbable scaffold | STENT SYSTEM
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 13, pp. E318 - E318
Results The percentage % change (median [IQR]) of the vessel cross-sectional area (CSA), lumen CSA & plaque CSA at the 5mm prox edge segment demonstrated... 
Cardiovascular | Internal Medicine
Journal Article
The International Journal of Cardiovascular Imaging, ISSN 1569-5794, 7/2011, Volume 27, Issue 6, pp. 859 - 866
Journal Article